Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
Gerresheimer reports muted Q1, free cash flow significantly improved and hopes for recovery
Gerresheimer reported Q1 revenue of €524m and adjusted EBITDA of €66m, with a margin of 12.6%. The free cash flow shortfall narrowed substantially to €32m after previously -€141m. Management expects earnings to improve in the second half and plans to sell Centor and Primary Packaging Plastics to strengthen the balance sheet. Delayed quarterly reports due to faulty accounting have damaged investor confidence and put SDAX status into question. » Altro su deraktionaer.de
Gerresheimer makes progress on balance sheet and debt reduction, operations still mixed
Gerresheimer has cleared balance-sheet issues tied to the delayed report and plans to sell Centor and Primary Packaging Plastics, which should significantly reduce debt. Operationally the first quarter remained weak: revenue around €524 million, adjusted EBITDA fell from €81 million to €66 million. Free cash flow improved markedly to -€32 million versus -€141 million a year earlier. Management expects a pickup in business momentum in the second half, which could further ease the metrics. » Altro su finanzen.net
Gerresheimer: adjusted EBITDA falls 19% – shares rise 2.8% after cash‑flow improvement
Gerresheimer reports adjusted EBITDA of €66m for Q1 2026 (-19%) and a margin of 12.6% (previous year 15.7%), on slightly higher revenue of €524m. Free cash flow improved significantly to -€32m from -€141m, driven by active inventory reduction and throttled production volumes, which weigh on profitability in the short term. The Containment & Delivery Systems segment performed positively with a higher margin due to strong demand and new U.S. production ramp‑ups. The quarterly release was delayed due to internal reviews of revenue recognition, the company still lacks a permanent CEO, and management is aiming for a turnaround in the second half. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | novembre 2025 | |
|---|---|---|
| Ricavi | 639,49 Mln | - |
| Utile lordo | 1,78 Mln | - |
| Utile netto | -306,63 Mln | - |
| EBITDA | 35,02 Mln | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 1,03 Mld € |
Numero di azioni | 34,54 Mln |
Massimo/minimo a 52 settimane | 44,76 € - 14,83 € |
| Dividendi | No |
Beta | 0,48 |
Rapporto P/E | -3,41 |
Rapporto PEG | 0,01 |
Rapporto P/B | 0,95 |
Rapporto P/S | 0,57 |
Profilo aziendale
Die Gerresheimer AG produziert und vertreibt zusammen mit ihren Tochtergesellschaften weltweit Verpackungsprodukte sowie Geräte und Lösungen zur Verabreichung von Medikamenten. Das Unternehmen ist in den Geschäftsbereichen Plastics & Devices, Primary Packaging Glass und Advanced Technologies tätig. Der Geschäftsbereich Plastics & Devices bietet Systeme zur Verabreichung von Medikamenten an, darunter Inhalatoren, Insulin-Pen-Systeme, vorfüllbare Spritzen und Diagnosesysteme für die Pharma-, Biotech-, Diagnostik- und Medizintechnikindustrie; Behälter und Verschlüsse, PET-Flaschen, Augentropfer, Nasensprays, Vernebler, Applikatoren und Zubehör für feste, flüssige und ophthalmische Anwendungen sowie Flaschen und Behälter für Nahrungsergänzungsmittel. Der Geschäftsbereich Primary Packaging Glass bietet Primärverpackungen aus Glas für die Pharma- und Kosmetikindustrie an, z. B. Infusions-, Tropfflaschen und Sirupflaschen, Injektionsfläschchen, Ampullen und Karpulen, Miniaturflaschen und Glasbehälter für flüssige Lebensmittel, Gewürze und Spirituosen sowie Verpackungslösungen für Parfüms, Deodorants, Hautpflege- und Wellnessprodukte sowie Beauty- und Pharmaprodukte. Der Geschäftsbereich Advanced Technologies entwickelt für Kunden aus der Pharma- und Biotech-Branche intelligente Verabreichungssysteme für Medikamente, wie z. B. Mikropumpen, die zur Selbstverabreichung von Medikamenten gegen die Parkinson-Krankheit oder Herzinsuffizienz eingesetzt werden. Das Unternehmen wurde 1864 gegründet und hat seinen Hauptsitz in Düsseldorf, Deutschland.
| Nome | Gerresheimer |
| CEO | Uwe Ferdinand Röhrhoff |
| Sede centrale | Düsseldorf,
nw Germania |
| Sito web | |
| Settore | Sanità |
| Industria | Tecnologia sanitaria |
| Quotazione in borsa | 11/06/2007 |
| Dipendenti | 13.528 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
XETRA | GXI.DE |
Pnk | GRRMF |
SIX | GXI.SW |
Frankfurt | GXI.F |
Düsseldorf | GXI.DU |
Hamburg | GXI.HM |
London | 0NTI.L |
München | GXI.MU |
Wien | GXI.VI |
Scopri gli asset
Gli azionisti di Gerresheimer investono anche nei seguenti asset